Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
Status:
Withdrawn
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an outpatient combination of lovastatin and
low-to-moderate dose interferon is effective in the treatment of patients with malignant
melanoma.
Phase:
Phase 2
Details
Lead Sponsor:
NeoPlas Innovation
Treatments:
Dihydromevinolin Interferon alpha-2 Interferon-alpha Interferons L 647318 Lovastatin